Cargando…
Clinical Determinants of Disease Progression in Patients With Beta-Sarcoglycan Gene Mutations
Background: Limb-girdle muscular dystrophy 2E (LGMD 2E), recently renamed as autosomal recessive limb-girdle muscular dystrophy-4 (LGMDR4), is characterized by the lack of beta-sarcoglycan, normally expressed in skeletal muscles and cardiomyocytes. We hypothesized that progressive respiratory and le...
Autores principales: | Marchetti, Giulia Bruna, Valenti, Luca, Torrente, Yvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280524/ https://www.ncbi.nlm.nih.gov/pubmed/34276533 http://dx.doi.org/10.3389/fneur.2021.657949 |
Ejemplares similares
-
Two-Generation Epsilon-Sarcoglycan Gene (SGCE) Mutation-Associated Myoclonus-Dystonia (DYT-SGCE) Misdiagnosed as Tourette’s Syndrome: A Case Series
por: Surillo-Dahdah, Laura, et al.
Publicado: (2023) -
Sarcolemmal deficiency of sarcoglycan complex in an 18-month-old Turkish boy with a large deletion in the beta sarcoglycan gene
por: Diniz, G, et al.
Publicado: (2016) -
Limb-girdle Muscular Dystrophy with New Mutation in Sarcoglycan Beta Gene: A Case Report
por: TAGHIZADEH, Eskandar, et al.
Publicado: (2018) -
Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial
por: Sitzia, Clementina, et al.
Publicado: (2019) -
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
por: Duclos, Franck, et al.
Publicado: (1998)